Collaborative Research Using Biosamples and/or Data from Type 1 Diabetes Clinical Studies (R01 - Clinical Trial Not Allowed)
Funding available for collaborative research on type 1 diabetes using biosamples and data from clinical studies to improve prevention strategies.
Browse similar grants
This grant is no longer accepting proposals
National Institutes of Health has archived this opportunity.
Funder: National Institutes of Health
Due Dates: May 26, 2025 (Letter of Intent & Open Date) | June 26, 2025 (Application Due) | February 6, 2026 (Letter of Intent) | March 6, 2026 (Application Due) | March 9, 2026 (Expiration)
Funding Amounts: Up to $1,200,000 direct costs/year (max 3 years); NIH expects to fund 3–4 awards per cycle, with $5.5M/year committed.
Summary: Supports collaborative research using biosamples and/or data from type 1 diabetes clinical studies to advance understanding of disease mechanisms and improve prevention.
Key Information: Clinical trials are not allowed; applicants must have documented access to eligible biosamples/data at submission.
Description
This NIH opportunity funds collaborative research projects that utilize existing biosamples and/or data from type 1 diabetes (T1D) clinical studies or trials. The goal is to accelerate research into the etiology and pathogenesis of T1D, with a focus on understanding disease mechanisms that can inform improved prevention strategies. Projects should leverage well-characterized human samples and datasets from established T1D studies, such as DPT-1, TrialNet, or TEDDY, to address key questions about disease progression, biomarkers, environmental triggers, and mechanisms of protection or susceptibility.
Clinical trials are not permitted under this funding announcement. Instead, the focus is on secondary analyses, biomarker discovery, mechanistic studies, and hypothesis-driven research using existing human data and biospecimens.
